<p>随着全球市场在复杂的经济环境中航行，亚洲股票凭借其多样化的机会继续吸引投资者的关注。便士股票通常代表较小或较新的公司，仍然是寻求低价位增长的投资者的一个引人注目的领域。尽管这个术语有些过时，但当这些股票有强大的财务支持和明确的增长潜力时，仍然可以提供显著的价值。</p>
<h3>亚洲十大便士股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.45</td>
<td>HK$896.85M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)</td>
<td>THB2.50</td>
<td>THB1.05B</td>
<td>✅ 3 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.56</td>
<td>HK$2.12B</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Panjawattana Plastic (SET:PJW)</td>
<td>THB2.04</td>
<td>THB1.18B</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Atlantic Navigation Holdings (Singapore) (Catalist:5UL)</td>
<td>SGD0.105</td>
<td>SGD54.97M</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD3.64</td>
<td>SGD14.33B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>NagaCorp (SEHK:3918)</td>
<td>HK$4.64</td>
<td>HK$20.52B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Livestock Improvement (NZSE:LIC)</td>
<td>NZ$1.00</td>
<td>NZ$137.01M</td>
<td>✅ 2 ⚠️ 5 查看分析 </td>
</tr>
<tr>
<td>Bosideng International Holdings (SEHK:3998)</td>
<td>HK$4.40</td>
<td>HK$51.08B</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Scott Technology (NZSE:SCT)</td>
<td>NZ$2.82</td>
<td>NZ$235.47M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
</tbody>
</table>
<p>点击这里查看我们亚洲便士股票筛选器的 958 只股票的完整列表。</p>
<p>下面我们展示了一些经过筛选的股票。</p>
<h2>Ley Choon Group Holdings (Catalist:Q0X)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Ley Choon Group Holdings Limited 是一家投资控股公司，提供新加坡和斯里兰卡的地下公用设施基础设施建设服务，市值为 SGD150.58 百万。</p>
<p><strong>运营：</strong> 公司的收入主要来自其管道和道路部门，贡献 SGD176.34 百万，以及其建筑材料部门，增加 SGD30.97 百万。</p>
<p><strong>市值：</strong> SGD150.58M</p>
<p>Ley Choon Group Holdings Limited 市值为 SGD150.58 百万，过去一年保持无债务并避免股东稀释，展现出稳定性。公司从其管道和道路部门（SGD176.34 百万）和建筑材料部门（SGD30.97 百万）产生显著收入，尽管最近的收益显示截至 2025 年 9 月的半年净收入略微下降至 SGD6.08 百万。其经验丰富的管理团队与缺乏经验的董事会形成对比，而短期资产足以覆盖短期和长期负债，支持在波动市场中的财务韧性。</p>
<ul>
<li>点击这里发现 Ley Choon Group Holdings 的细微差别，查看我们的详细分析财务健康报告。</li>
<li>查看我们的历史业绩报告，以获取 Ley Choon Group Holdings 的业绩记录。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7f961e36-871c-4c6c-8b6f-aae9f2450ada/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7f961e36-871c-4c6c-8b6f-aae9f2450ada/chart/debt-equity-history-analysis"/></p>
<p>Catalist:Q0X 债务与股本历史及分析截至 2026 年 1 月</p>
<h2>Sipai Health Technology (SEHK:314)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> Sipai Health Technology Co., Ltd.是一家在中华人民共和国运营的医疗技术和健康管理公司，市值为 HK$2.07 亿。</p>
<p><strong>运营：</strong> Sipai Health Technology 的收入主要来自其专业药房业务，贡献 CN¥2.83 亿，其次是医生研究辅助业务，贡献 CN¥425.36 百万，以及健康保险服务业务，贡献 CN¥166.43 百万。</p>
<p><strong>市值：</strong> HK$2.07B</p>
<p>Sipai Health Technology 市值为 HK$2.07 亿，主要通过其专业药房业务产生 CN¥2.83 亿的收入。尽管目前处于亏损状态，并预计在未来三年内不会实现盈利，但公司在过去五年中将损失减少了 53.1%，并预测年收入增长率为 15.27%。其交易价格低于估计公允价值的 70.9%，并且在当前自由现金流的基础上保持无债务，现金流足够支撑超过三年的运营，同时其经验丰富的管理团队在最近的董事会变动中支持战略稳定。</p>
<ul>
<li>通过阅读我们的资产负债表健康报告，深入了解 Sipai Health Technology 的表现。</li>
<li>通过检查我们的增长报告，了解 Sipai Health Technology 的盈利前景。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/89a248de-4029-4a6c-8722-091007f2d55d/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/89a248de-4029-4a6c-8722-091007f2d55d/chart/financial-position-analysis"/></p>
<p>SEHK:314 财务状况分析截至 2026 年 1 月</p>
<h2>Adicon Holdings (SEHK:9860)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Adicon Holdings Limited 是一家投资控股公司，提供在中华人民共和国的医疗检测服务，市值为 HK$3.20 亿。</p>
<p><strong>运营：</strong> 公司的收入主要来自其医疗设施与服务部门，总计 CN¥2.72 亿。</p>
<p><strong>市值：</strong> HK$3.2B</p>
<p>艾迪康控股的市值为 32 亿港元，其 27.2 亿人民币的收入来自中国的医疗服务。尽管在过去五年中处于亏损状态并经历了损失增加，但其每周波动率保持在 6% 的稳定水平，净负债与股本比率为 32.5%，表现令人满意。公司的短期资产（29 亿人民币）超过了短期负债（19 亿人民币）和长期负债（8.658 亿人民币）。尽管朱乔纳森先生最近辞去了董事会职务，艾迪康的管理团队仍然经验丰富，平均任期为 4.2 年，支持未来潜在的战略举措。</p>
<ul>
<li>通过我们的综合资产负债表健康报告，深入了解艾迪康控股的复杂性。</li>
<li>查看我们的增长表现报告，以获取关于艾迪康控股未来的见解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4a50de19-77c6-4173-aab9-81d2af195aa5/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4a50de19-77c6-4173-aab9-81d2af195aa5/chart/revenue-and-expenses-breakdown"/></p>
<p>SEHK:9860 截至 2026 年 1 月的收入与支出明细</p>
<h2>将想法转化为行动</h2>
<ul>
<li>深入了解我们识别的所有 958 只亚洲便士股票。</li>
<li>准备进入其他投资风格吗？这项技术可能取代计算机：发现 29 只股票正在努力使量子计算成为现实。</li>
</ul>
<p><em>本文由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不构成财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>

立堾集团控股

艾迪康控股

思派健康

<p>亚洲股票，特别是便士股票，因其在较低价格点的增长潜力而吸引了投资者的关注。值得注意的选择包括立堾集团控股、思派健康科技和艾迪康控股，它们各自具有独特的市场定位和财务健康评级。立堾集团市值为 1.5058 亿新加坡元，显示出稳定性，没有债务，但净收入略有下降。思派健康科技的估值为 20.7 亿港元，虽然尚未盈利，但预计将实现显著的收入增长。艾迪康控股市值为 32 亿港元，虽然也面临亏损，但保持了稳健的财务状况</p>

<p>As global markets navigate a complex economic landscape, Asian equities continue to capture investor attention with their diverse opportunities. Penny stocks, often representing smaller or newer companies, remain an intriguing segment for investors seeking growth at lower price points. Despite the term's vintage connotations, these stocks can offer significant value when backed by strong financials and clear growth potential.</p>
<div class="lb-trans"><p>随着全球市场在复杂的经济环境中航行，亚洲股票凭借其多样化的机会继续吸引投资者的关注。便士股票通常代表较小或较新的公司，仍然是寻求低价位增长的投资者的一个引人注目的领域。尽管这个术语有些过时，但当这些股票有强大的财务支持和明确的增长潜力时，仍然可以提供显著的价值。</p>
</div><h3>Top 10 Penny Stocks In Asia</h3>
<div class="lb-trans"><h3>亚洲十大便士股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.45</td>
<td>HK$896.85M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)</td>
<td>THB2.50</td>
<td>THB1.05B</td>
<td>✅ 3 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.56</td>
<td>HK$2.12B</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Panjawattana Plastic (SET:PJW)</td>
<td>THB2.04</td>
<td>THB1.18B</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Atlantic Navigation Holdings (Singapore) (Catalist:5UL)</td>
<td>SGD0.105</td>
<td>SGD54.97M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD3.64</td>
<td>SGD14.33B</td>
<td>✅ 5 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>NagaCorp (SEHK:3918)</td>
<td>HK$4.64</td>
<td>HK$20.52B</td>
<td>✅ 5 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Livestock Improvement (NZSE:LIC)</td>
<td>NZ$1.00</td>
<td>NZ$137.01M</td>
<td>✅ 2 ⚠️ 5 View Analysis &gt;</td>
</tr>
<tr>
<td>Bosideng International Holdings (SEHK:3998)</td>
<td>HK$4.40</td>
<td>HK$51.08B</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Scott Technology (NZSE:SCT)</td>
<td>NZ$2.82</td>
<td>NZ$235.47M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.45</td>
<td>HK$896.85M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)</td>
<td>THB2.50</td>
<td>THB1.05B</td>
<td>✅ 3 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.56</td>
<td>HK$2.12B</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Panjawattana Plastic (SET:PJW)</td>
<td>THB2.04</td>
<td>THB1.18B</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Atlantic Navigation Holdings (Singapore) (Catalist:5UL)</td>
<td>SGD0.105</td>
<td>SGD54.97M</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD3.64</td>
<td>SGD14.33B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>NagaCorp (SEHK:3918)</td>
<td>HK$4.64</td>
<td>HK$20.52B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Livestock Improvement (NZSE:LIC)</td>
<td>NZ$1.00</td>
<td>NZ$137.01M</td>
<td>✅ 2 ⚠️ 5 查看分析 </td>
</tr>
<tr>
<td>Bosideng International Holdings (SEHK:3998)</td>
<td>HK$4.40</td>
<td>HK$51.08B</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Scott Technology (NZSE:SCT)</td>
<td>NZ$2.82</td>
<td>NZ$235.47M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 958 stocks from our Asian Penny Stocks screener.</p>
<div class="lb-trans"><p>点击这里查看我们亚洲便士股票筛选器的 958 只股票的完整列表。</p>
</div><p>Underneath we present a selection of stocks filtered out by our screen.</p>
<div class="lb-trans"><p>下面我们展示了一些经过筛选的股票。</p>
</div><h2>Ley Choon Group Holdings (Catalist:Q0X)</h2>
<div class="lb-trans"><h2>Ley Choon Group Holdings (Catalist:Q0X)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Ley Choon Group Holdings Limited is an investment holding company that offers underground utilities infrastructure construction services in Singapore and Sri Lanka, with a market capitalization of SGD150.58 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Ley Choon Group Holdings Limited 是一家投资控股公司，提供新加坡和斯里兰卡的地下公用设施基础设施建设服务，市值为 SGD150.58 百万。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily generated from its Pipes and Roads segment, contributing SGD176.34 million, and its Construction Materials segment, which adds SGD30.97 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入主要来自其管道和道路部门，贡献 SGD176.34 百万，以及其建筑材料部门，增加 SGD30.97 百万。</p>
</div><p><strong>Market Cap:</strong> SGD150.58M</p>
<div class="lb-trans"><p><strong>市值：</strong> SGD150.58M</p>
</div><p>Ley Choon Group Holdings Limited, with a market capitalization of SGD150.58 million, has demonstrated stability by maintaining no debt and avoiding shareholder dilution over the past year. The company generates significant revenue from its Pipes and Roads segment (SGD176.34 million) and Construction Materials segment (SGD30.97 million), though recent earnings showed a slight decline in net income to SGD6.08 million for the half-year ended September 2025 compared to the previous year. Its experienced management team contrasts with an inexperienced board, while short-term assets comfortably cover both short- and long-term liabilities, supporting financial resilience in volatile markets.</p>
<div class="lb-trans"><p>Ley Choon Group Holdings Limited 市值为 SGD150.58 百万，过去一年保持无债务并避免股东稀释，展现出稳定性。公司从其管道和道路部门（SGD176.34 百万）和建筑材料部门（SGD30.97 百万）产生显著收入，尽管最近的收益显示截至 2025 年 9 月的半年净收入略微下降至 SGD6.08 百万。其经验丰富的管理团队与缺乏经验的董事会形成对比，而短期资产足以覆盖短期和长期负债，支持在波动市场中的财务韧性。</p>
</div><ul>
<li>Click here to discover the nuances of Ley Choon Group Holdings with our detailed analytical financial health report.</li>
<li>Review our historical performance report to gain insights into Ley Choon Group Holdings' track record.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里发现 Ley Choon Group Holdings 的细微差别，查看我们的详细分析财务健康报告。</li>
<li>查看我们的历史业绩报告，以获取 Ley Choon Group Holdings 的业绩记录。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7f961e36-871c-4c6c-8b6f-aae9f2450ada/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/7f961e36-871c-4c6c-8b6f-aae9f2450ada/chart/debt-equity-history-analysis"/></p>
<p>Catalist:Q0X Debt to Equity History and Analysis as at Jan 2026</p>
<div class="lb-trans"><p>Catalist:Q0X 债务与股本历史及分析截至 2026 年 1 月</p>
</div><h2>Sipai Health Technology (SEHK:314)</h2>
<div class="lb-trans"><h2>Sipai Health Technology (SEHK:314)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Sipai Health Technology Co., Ltd. is a medical technology and health management company operating in the People's Republic of China, with a market cap of HK$2.07 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Sipai Health Technology Co., Ltd.是一家在中华人民共和国运营的医疗技术和健康管理公司，市值为 HK$2.07 亿。</p>
</div><p><strong>Operations:</strong> Sipai Health Technology generates revenue primarily from its Specialty Pharmacy Business, which accounts for CN¥2.83 billion, followed by the Physician Research Assistance Business at CN¥425.36 million and the Health Insurance Services Business at CN¥166.43 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> Sipai Health Technology 的收入主要来自其专业药房业务，贡献 CN¥2.83 亿，其次是医生研究辅助业务，贡献 CN¥425.36 百万，以及健康保险服务业务，贡献 CN¥166.43 百万。</p>
</div><p><strong>Market Cap:</strong> HK$2.07B</p>
<div class="lb-trans"><p><strong>市值：</strong> HK$2.07B</p>
</div><p>Sipai Health Technology, with a market cap of HK$2.07 billion, operates primarily through its Specialty Pharmacy Business generating CN¥2.83 billion in revenue. Despite being unprofitable and not expected to achieve profitability in the next three years, the company has reduced losses by 53.1% annually over five years and forecasts a 15.27% annual revenue growth rate. It trades at 70.9% below estimated fair value and remains debt-free with sufficient cash runway for over three years based on current free cash flow, while its experienced management team supports strategic stability amidst recent board changes.</p>
<div class="lb-trans"><p>Sipai Health Technology 市值为 HK$2.07 亿，主要通过其专业药房业务产生 CN¥2.83 亿的收入。尽管目前处于亏损状态，并预计在未来三年内不会实现盈利，但公司在过去五年中将损失减少了 53.1%，并预测年收入增长率为 15.27%。其交易价格低于估计公允价值的 70.9%，并且在当前自由现金流的基础上保持无债务，现金流足够支撑超过三年的运营，同时其经验丰富的管理团队在最近的董事会变动中支持战略稳定。</p>
</div><ul>
<li>Get an in-depth perspective on Sipai Health Technology's performance by reading our balance sheet health report here.</li>
<li>Understand Sipai Health Technology's earnings outlook by examining our growth report.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过阅读我们的资产负债表健康报告，深入了解 Sipai Health Technology 的表现。</li>
<li>通过检查我们的增长报告，了解 Sipai Health Technology 的盈利前景。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/89a248de-4029-4a6c-8722-091007f2d55d/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/89a248de-4029-4a6c-8722-091007f2d55d/chart/financial-position-analysis"/></p>
<p>SEHK:314 Financial Position Analysis as at Jan 2026</p>
<div class="lb-trans"><p>SEHK:314 财务状况分析截至 2026 年 1 月</p>
</div><h2>Adicon Holdings (SEHK:9860)</h2>
<div class="lb-trans"><h2>Adicon Holdings (SEHK:9860)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Adicon Holdings Limited is an investment holding company that offers medical testing services in the People’s Republic of China, with a market cap of HK$3.20 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Adicon Holdings Limited 是一家投资控股公司，提供在中华人民共和国的医疗检测服务，市值为 HK$3.20 亿。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily derived from its Healthcare Facilities &amp; Services segment, totaling CN¥2.72 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入主要来自其医疗设施与服务部门，总计 CN¥2.72 亿。</p>
</div><p><strong>Market Cap:</strong> HK$3.2B</p>
<div class="lb-trans"><p><strong>市值：</strong> HK$3.2B</p>
</div><p>Adicon Holdings, with a market cap of HK$3.20 billion, derives its CN¥2.72 billion revenue from healthcare services in China. Despite being unprofitable and experiencing increased losses over the past five years, it maintains stable weekly volatility at 6% and has a satisfactory net debt to equity ratio of 32.5%. The company’s short-term assets (CN¥2.9 billion) exceed both short-term liabilities (CN¥1.9 billion) and long-term liabilities (CN¥865.8 million). Although Mr. Zhu Jonathan resigned from the board recently, Adicon's management team remains experienced with an average tenure of 4.2 years, supporting potential strategic initiatives moving forward.</p>
<div class="lb-trans"><p>艾迪康控股的市值为 32 亿港元，其 27.2 亿人民币的收入来自中国的医疗服务。尽管在过去五年中处于亏损状态并经历了损失增加，但其每周波动率保持在 6% 的稳定水平，净负债与股本比率为 32.5%，表现令人满意。公司的短期资产（29 亿人民币）超过了短期负债（19 亿人民币）和长期负债（8.658 亿人民币）。尽管朱乔纳森先生最近辞去了董事会职务，艾迪康的管理团队仍然经验丰富，平均任期为 4.2 年，支持未来潜在的战略举措。</p>
</div><ul>
<li>Navigate through the intricacies of Adicon Holdings with our comprehensive balance sheet health report here.</li>
<li>Review our growth performance report to gain insights into Adicon Holdings' future.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过我们的综合资产负债表健康报告，深入了解艾迪康控股的复杂性。</li>
<li>查看我们的增长表现报告，以获取关于艾迪康控股未来的见解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4a50de19-77c6-4173-aab9-81d2af195aa5/chart/revenue-and-expenses-breakdown" alt="" original-src="https://images.simplywall.st/company/4a50de19-77c6-4173-aab9-81d2af195aa5/chart/revenue-and-expenses-breakdown"/></p>
<p>SEHK:9860 Revenue &amp; Expenses Breakdown as at Jan 2026</p>
<div class="lb-trans"><p>SEHK:9860 截至 2026 年 1 月的收入与支出明细</p>
</div><h2>Turning Ideas Into Actions</h2>
<div class="lb-trans"><h2>将想法转化为行动</h2>
</div><ul>
<li>Dive into all 958 of the Asian Penny Stocks we have identified here.</li>
<li>Ready To Venture Into Other Investment Styles? This technology could replace computers: discover the 29 stocks are working to make quantum computing a reality.</li>
</ul>
<div class="lb-trans"><ul>
<li>深入了解我们识别的所有 958 只亚洲便士股票。</li>
<li>准备进入其他投资风格吗？这项技术可能取代计算机：发现 29 只股票正在努力使量子计算成为现实。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>本文由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不构成财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div>

亚洲便士股亮点：立堾集团控股及其他两个值得关注的选择